Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

September 16, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Mutations associated with neuropsychiatric conditions contributing to psychiatric dysfunction

AcSIR Admissions Notification | Jan & Aug 2021 Session

Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

Mutations associated with neuropsychiatric conditions contributing to psychiatric dysfunction
  • BiotechToday
  • World

Mutations associated with neuropsychiatric conditions contributing to psychiatric dysfunction

bioxone October 21, 2020October 20, 2020

PRAGYA SANTRA, AMITY UNIVERSITY KOLKATA

Mutation and copy number variants (CNV) are a great risk-factor for Autism Spectrum Disorder (ASD), schizophrenia (SZ), and Attention-Deficit-Hyperactivity-Disorder (ADHD). But its association with functional brain connectivity (FC) is unknown. FC-changes may not surely represent an intermediate brain phenotype but a secondary impact of psychiatric illnesses. Individuals with a high frequency of deletion and duplication of gene exhibit worse cognitive and behavioural status. Increase genetic variation and CNV burden results in neurodevelopmental and psychiatric disorder. 

CNVs at the genomic loci 16p11.2 and 22q11.2 are more prone to genetic variations. Precisely, deletion of 37 and 24 genes in the 22q11.2 and 16p11.2 respectively resulted in changing expressions. They grant to high risk for ASD. Gene dosage resulted in structural alterations of the cingulate, insula, precuneus, and superior temporal gyrus. Other large size mutations confer genetic risks connected to brain endophenotypes representing intrinsic low-frequency synchronization to neuroanatomical arenas. 

43.2% deletion of 22q11.2 targets to dysconnectivity of thalamic-hippocampal circuitry, predictive of prodromal psychotic symptoms. The connections among anterior and lateral DMN, limbic network temporal pole, the ventral anterior insula and peri-insular sulcus, the amygdala-hippocampal complex, the dorsal anterior cingulate cortex, and pregenual anterior cingulate cortex are altered drastically. Besides duplication of 22q11.2 leads to over-connectivity in the posterior medial and lateral visual network, cerebellum I-V and lateral fusiform gyrus.

24.2% deletion of 16p11.2 focuses on alteration of connectivity among frontoparietal, somatomotor, ventral attention and basal ganglia networks. SZ individuals direct on increased similarities of thalamic-sensorimotor dysconnectivity across CNVs and psychiatric conditions. But for the duplication of 16p11.2, none of the patients survives. 

Individuals having autism shows greater similarity with 6-regional FC-signatures of 16p11.2 deletion and greater similarity with 6-region-level FC-signatures of the 22q11.2 deletion. 8 &6 out of the top 10 regions altered by 22q11.2 and 16p11.2 respectively alters psychiatric conditions. Among the idiopathic conditions due to the mutation, the connectivity alteration is maximum in SZ followed by autism and ADHD. Regional FC-signatures of gene dosage, in particular, those compromising the thalamus, somatomotor, posterior insula and cingulate showed marked coincidence with the complex architecture of idiopathic ASD, SZ, autism but not ADHD. 

Individuals with all over-connectivities and under-connectivities witness sensory-motor, auditory and visual disbalances with psychiatric illness. The thought process and perseverance of situations vary in such patients. Auditory and visuals hallucinations, impairments in gestalt visual perception and discrimination of visual motion, disturbances in auditory and tactile discrimination are serious threats to the genetic mutations.

Apart from these studies, the mechanism of psychiatric control under genetic manifestation is still a miracle. Large-scale research on common psychiatric outcomes associated with genetic variants and FC-signatures are still in progress.

Also read: Bluetongue Disease: a viral disease

SOURCE

  1. Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia; Clara A. Moreau et al; 19 October 2020, Nature Communications, Volume: 11, Pg no.: 5272 doi:  https://doi.org/10.1038/s41467-020-18997-2 
  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Attention-Deficit-Hyperactivity-Disorder (ADHD) Autism Spectrum disorder (ASD) connectivity copy number variants (CNV) deletion duplication endophenotypes FC signatures functional brain connectivity (FC) gene dosage Gene editing genes genetic variations idiopathic conditions make-up Mutation network neuro neurodevelopmental psychiatric research schizophrenia (SZ)

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Multiple Antibody Panel to treat Esophageal Squamous Cell Carcinoma (ESCC)

bioxone October 21, 2020

Chitra Roy, University of Calcutta Cancer Immunotherapy work by helping the immune system to function in an efficient manner to fight cancer cells. For the immune system to start its response, it must first be able to identify and differentiate between self-part of your own body and non-self-foreign/antigen. Cancer Immunotherapy is generally divided in two […]

Antibody

Related Post

  • BiotechToday
  • World

Appendicitis – Antibiotics or Appendectomy?

bioxone October 7, 2020October 7, 2020

Thota Kanishka Rao, Amity University Kolkata Appendectomy has for quite some time been the standard treatment for appendicitis, even though effective utilisation of anti-microbial therapy as an option was accounted for over 60 years. Even in recent years, more than 95% of U.S. patients with appendicitis underwent an appendectomy. However, with the ongoing Covid-19 pandemic, […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

ECMO: An artificial heart-lung set for COVID-19 treatment

bioxone June 22, 2021June 23, 2021

Avani Dave, Jai Hind College Extracorporeal membrane oxygenation (ECMO) acts as an artificial set of the heart and lungs, allowing a patient’s respiratory foundation to rest while proceeding towards a hopeful recovery. This mechanism has been put in a good word for, particularly during the two consecutive and rampant waves of the COVID-19 pandemic. ECMO […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

X10-23 reagent improves the activity of DNAzymes!

bioxone April 3, 2021April 3, 2021

Devyani Goswami, Amity University Kolkata DNAzymes area type of DNA catalysts. DNAzymes are known for their specialty in catalyzing site-specific cleavage of any RNA substrate. RNA-cleaving DNA enzyme has a catalytic core and two short binding arms which form Watson and Crick base pairs with the RNA targets. RNA cleavage is possible with the assistance […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy